๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX ยท Real-Time Price ยท USD
0.1465
-0.0135 (-8.44%)
At close: Nov 18, 2026, 4:00 PM EST
0.1485
+0.0020 (1.37%)
After-hours: Nov 18, 2026, 7:07 PM EST

Mangoceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.30.460.620.730.01-
Revenue Growth
-35.64%-25.96%-15.81%8083.16%--
Gross Profit
0.160.250.380.430-
Operating Income
-9.79-17.59-8.24-8.12-1.99-0.07
Net Income
-12.21-21.82-9.51-9.21-2-0.07
Earnings Per Share
-0.72-2.17-4.80-8.58-2.78-
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.661.490.060.740.680.02
Total Debt
0.640.310.210.130.350.04
Net Cash (Debt)
0.021.18-0.160.610.33-0.02
Net Cash Growth
-94.18%--84.95%--
Net Cash Per Share
0.000.12-0.080.570.46-0.03

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.8-5.85-4.86-7-1.35-0.07
Capital Expenditures
----0-0.04-
Free Cash Flow
-3.8-5.85-4.86-7-1.39-0.07
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.94%54.91%61.70%58.99%54.26%-
Operating Margin
-3258.25%-3858.11%-1337.90%-1109.84%-22279.70%-
Pretax Margin
-3673.73%-4526.86%-1413.80%-1259.40%-22352.11%-
Profit Margin
-4065.07%-4784.65%-1543.87%-1259.40%-22352.11%-
FCF Margin
-1264.41%-1282.89%-789.74%-957.07%-15545.59%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.8424.9710.077.96--